LEARNING OBJECTIVES

At the conclusion of our educational meeting, the participant will be able to:

  • Acquaint with the new staging and pathology classification systems in lung cancer
  • Recognize the clinical significance of molecular genotyping of lung cancer patients
  • Understand the molecular pathways that hold promise for therapeutic intervention in lung cancer patients
  • Update of Immunotherapy strategies for lung cancer
  • Discuss the optimal methodology of evaluation of response in the era of translational research
  • Recognize the importance of a multidisciplinary approach to the care of lung cancer patients 

 

 

TOPICS

  • Neuroendocrine lung cancer update
  • Thymic cancer update
  • Tumor heterogeneity
  • Prognostic and predictive tumor markers
  • Molecular signaling of LC
  • NSCLC driver oncogenes
  • Immunotherapy
  • Evaluation of response
  • Masterprotocols in lung cancer
  • Agents related-toxicity management
  • Newer generation TKIs inhibitors

 

 

 

Learning Objectives & Topics

5th Lung Cancer Network «From the Bench to the Bedside»

4th Lung Cancer Network «From the Bench to the Bedside»

4th Lung Cancer Network «From the Bench to the Bedside»

Congress Secretariat

 logo ets copy

E.T.S. Events & Travel Solutions S.A.
154 El. Venizelou Str
N. Smyrni, Athens, Greece, 171 22
Tel.: +30 210 98 80 032
Fax.: +30 210 98 81 303
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Website: www.events.gr

Scroll to top